Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2
Key facts
- Who runs it
- Hamilton Health Sciences Corporation
- Where
- Canada3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 20,000 people, planned
- Started
- Jun 2026
- Expected to end
- Jun 2032
- Type of study
- Observational
- Treatments tested
- Continuous vital signs measurement device
- Record updated
- 14 April 2026
Who can take part
- Age
- 65 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- age ≥65 years
- underwent non-cardiac surgery with general, neuraxial, local, or regional anesthesia; and
- expected length of hospital stay of 3 or more days
Who cannot take part
- hearing aid(s) or cochlear implant(s) in left ear
- previous enrollment in the VISION-2 Study
- intolerance/allergy to adhesive
- history of dementia, or
- pacemaker/implantable cardioverter-defibrillator (ICD)
- externally programmable cerebrospinal fluid shunt
- deep brain stimulator
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
VISION-2 is an international, multi-site, prospective observational cohort study of 20,000 patients undergoing noncardiac surgery. Continuous biometric data will be blindly collected for the first 30 postoperative days, in hospital and at home, using Vitaliti™. Following study enrollment and baseline data collection, follow up visits will occur in-hospital, at 30-days, and 1-year post-operatively.
Read full original descriptionShow less
VISION-2 has 3 primary objectives, among participants who underwent noncardiac surgery, the investigators will: 1) determine the pattern and frequency of physiological precursors (i.e., biophysical signals) to MINS, BIMS, sepsis, and infection without sepsis; 2) build prediction models from these biophysical signals and their extracted features through supervised machine learning, for the prediction and early detection of those complications; and 3) build a biobank for evaluation of novel biomarkers.
Treatments tested
- Continuous vital signs measurement device
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 14 April 2026